19562-43-7 Usage
Molecular structure
Use in research
It serves as a building block or intermediate for the synthesis of various compounds.
Commonly employed in organic and medicinal chemistry research.
Therapeutic potential
Suitable for developing drugs targeting specific biological pathways and processes.
Application in pharmaceutical development
Used as a key starting material for the development of new pharmaceuticals.
Properties
Benzamide derivative
Contains an amino group (NH2) and an ethoxyphenyl group
Suitable for medicinal chemistry due to its structure and properties
Check Digit Verification of cas no
The CAS Registry Mumber 19562-43-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,5,6 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 19562-43:
(7*1)+(6*9)+(5*5)+(4*6)+(3*2)+(2*4)+(1*3)=127
127 % 10 = 7
So 19562-43-7 is a valid CAS Registry Number.
InChI:InChI=1/C15H16N2O2/c1-2-19-12-9-7-11(8-10-12)17-15(18)13-5-3-4-6-14(13)16/h3-10H,2,16H2,1H3,(H,17,18)
19562-43-7Relevant articles and documents
CXCR3 antagonists
-
, (2008/06/13)
Compounds, compositions and methods that are useful in the treatment of inflammatory and immune conditions and diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of a chemokine receptor. The subject methods are useful for the treatment of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes.
